Disposition study of the novel dipeptidyl peptidase 4 inhibitor cetagliptin in rats. (4th May 2022)
- Record Type:
- Journal Article
- Title:
- Disposition study of the novel dipeptidyl peptidase 4 inhibitor cetagliptin in rats. (4th May 2022)
- Main Title:
- Disposition study of the novel dipeptidyl peptidase 4 inhibitor cetagliptin in rats
- Authors:
- Lu, Jinmiao
Hao, Yan
Zhang, Fuzhi
Pan, Huiping
Ding, Juping
Yu, Qiang
Wang, Tong - Abstract:
- Abstract: Dipeptidyl peptidase-4 (DPP-4) inhibitor is a class of oral antihyperglycemic agents and therapeutic approach for type 2 diabetes. Cetagliptin is a novel oral and selective DPP-4 inhibitor and developed as a promising candidate for treatment of type 2 diabetes mellitus. This study aimed to evaluate the metabolism and excretion of cetagliptin in Sprague-Dawley (SD) rats, and to detect and identify metabolites of cetagliptin. The SD rats were administered with a single oral dose of 6 mg/kg with approximately 100 µCi of [ 14 C] cetagliptin. The mean total recovery of radioactivity was 90.20% within 168h in SD rats excreta. Cetagliptin was the major radioactive component in SD rats plasma, urine and eliminated primarily by faecal excretion. The recovery of cetagliptin in urine and feces was 25.15% and 13.85% of the dose, respectively. Cetagliptin was well absorbed after oral administration in SD rats based on the total recovery of radioactivity in BDC SD rats bile and urine. Six major metabolites were observed and identified in SD rats, comprising 0.20 to 4.53% of total plasma AUC. These major metabolites were the hydroxylated, N-sulphate and N-carbamoyl glucuronic acid conjugates of the cetagliptin, two metabolites formed by glucuronide of a hydroxylated metabolite.
- Is Part Of:
- Xenobiotica. Volume 52:Number 5(2022)
- Journal:
- Xenobiotica
- Issue:
- Volume 52:Number 5(2022)
- Issue Display:
- Volume 52, Issue 5 (2022)
- Year:
- 2022
- Volume:
- 52
- Issue:
- 5
- Issue Sort Value:
- 2022-0052-0005-0000
- Page Start:
- 468
- Page End:
- 475
- Publication Date:
- 2022-05-04
- Subjects:
- Cetagliptin -- metabolism -- excretion -- metabolite -- dipeptidyl peptidase-4 inhibitor
Metabolism -- Periodicals
Drugs -- Physiological effect -- Periodicals
Food additives -- Periodicals
Chemicals -- Physiological effect -- Periodicals
Biochemistry -- Periodicals
Pharmaceutical Preparations -- metabolism -- Periodicals
Metabolism -- Periodicals
574.133 - Journal URLs:
- http://informahealthcare.com/journal/xen ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/00498254.2022.2091494 ↗
- Languages:
- English
- ISSNs:
- 0049-8254
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9367.020000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 23410.xml